Published in Psychopharmacology (Berl) on June 10, 2008
The neuropsychopharmacology of fronto-executive function: monoaminergic modulation. Annu Rev Neurosci (2009) 3.79
Inverted-U-shaped dopamine actions on human working memory and cognitive control. Biol Psychiatry (2011) 3.78
From reactive to proactive and selective control: developing a richer model for stopping inappropriate responses. Biol Psychiatry (2010) 3.39
Distinct frontal systems for response inhibition, attentional capture, and error processing. Proc Natl Acad Sci U S A (2010) 2.35
How the neurocircuitry and genetics of fear inhibition may inform our understanding of PTSD. Am J Psychiatry (2010) 2.24
Cognitive control and right ventrolateral prefrontal cortex: reflexive reorienting, motor inhibition, and action updating. Ann N Y Acad Sci (2011) 2.11
Left inferior frontal gyrus is critical for response inhibition. BMC Neurosci (2008) 2.10
Reconciling the role of serotonin in behavioral inhibition and aversion: acute tryptophan depletion abolishes punishment-induced inhibition in humans. J Neurosci (2009) 2.04
Is there an inhibitory-response-control system in the rat? Evidence from anatomical and pharmacological studies of behavioral inhibition. Neurosci Biobehav Rev (2009) 1.74
Stimulation of the subthalamic nucleus and impulsivity: release your horses. Ann Neurol (2009) 1.62
Insight into the relationship between impulsivity and substance abuse from studies using animal models. Alcohol Clin Exp Res (2010) 1.62
Cognitive enhancement as a treatment for drug addictions. Neuropharmacology (2012) 1.54
Rapid-response impulsivity: definitions, measurement issues, and clinical implications. Personal Disord (2015) 1.52
Striatal dopamine D₂/D₃ receptors mediate response inhibition and related activity in frontostriatal neural circuitry in humans. J Neurosci (2012) 1.44
Increased forebrain activations in youths with family histories of alcohol and other substance use disorders performing a Go/NoGo task. Alcohol Clin Exp Res (2014) 1.44
Functional networks for cognitive control in a stop signal task: independent component analysis. Hum Brain Mapp (2011) 1.43
The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders. Br J Pharmacol (2011) 1.39
Reversal learning as a measure of impulsive and compulsive behavior in addictions. Psychopharmacology (Berl) (2011) 1.34
Dopaminergic control of cognitive flexibility in humans and animals. Front Neurosci (2013) 1.28
Dissociable control of impulsivity in rats by dopamine d2/3 receptors in the core and shell subregions of the nucleus accumbens. Neuropsychopharmacology (2010) 1.19
Recent research on impulsivity in individuals with drug use and mental health disorders: implications for alcoholism. Alcohol Clin Exp Res (2010) 1.19
Dissecting impulsivity and its relationships to drug addictions. Ann N Y Acad Sci (2014) 1.19
Adults with a family history of alcohol related problems are more impulsive on measures of response initiation and response inhibition. Drug Alcohol Depend (2011) 1.18
Prefrontal and monoaminergic contributions to stop-signal task performance in rats. J Neurosci (2011) 1.17
Acute effects of morphine on distinct forms of impulsive behavior in rats. Psychopharmacology (Berl) (2009) 1.13
Neural mechanisms of impaired fear inhibition in posttraumatic stress disorder. Front Behav Neurosci (2011) 1.13
Improving response inhibition systems in frontotemporal dementia with citalopram. Brain (2015) 1.12
Reduced neural activation during an inhibition task is associated with impaired fear inhibition in a traumatized civilian sample. Cortex (2012) 1.11
Reliance on habits at the expense of goal-directed control following dopamine precursor depletion. Psychopharmacology (Berl) (2011) 1.10
Pharmacological enhancement of memory and executive functioning in laboratory animals. Neuropsychopharmacology (2010) 1.10
Characterizing cognitive aging of working memory and executive function in animal models. Front Aging Neurosci (2012) 1.09
Converging pharmacological and genetic evidence indicates a role for steroid sulfatase in attention. Biol Psychiatry (2009) 1.07
Blockade of NMDA GluN2B receptors selectively impairs behavioral flexibility but not initial discrimination learning. Psychopharmacology (Berl) (2011) 1.05
Characterizing cognitive aging in humans with links to animal models. Front Aging Neurosci (2012) 1.01
Methylphenidate and atomoxetine inhibit social play behavior through prefrontal and subcortical limbic mechanisms in rats. J Neurosci (2015) 0.98
Out of control: evidence for anterior insula involvement in motor impulsivity and reactive aggression. Soc Cogn Affect Neurosci (2014) 0.98
Challenges for translational psychopharmacology research--some basic principles. Psychopharmacology (Berl) (2008) 0.97
The role of serotonin in the regulation of patience and impulsivity. Mol Neurobiol (2012) 0.97
Noradrenergic versus dopaminergic modulation of impulsivity, attention and monitoring behaviour in rats performing the stop-signal task: possible relevance to ADHD. Psychopharmacology (Berl) (2013) 0.97
Frontal cortex-like functions of the subthalamic nucleus. Front Syst Neurosci (2011) 0.95
Objectively-measured impulsivity and attention-deficit/hyperactivity disorder (ADHD): testing competing predictions from the working memory and behavioral inhibition models of ADHD. J Abnorm Child Psychol (2012) 0.94
The role of the lateral prefrontal cortex in inhibitory motor control. Cortex (2012) 0.94
Dopamine and inhibitory action control: evidence from spontaneous eye blink rates. Exp Brain Res (2009) 0.93
Acute nicotine increases both impulsive choice and behavioural disinhibition in rats. Psychopharmacology (Berl) (2011) 0.93
Three key regions for supervisory attentional control: evidence from neuroimaging meta-analyses. Neurosci Biobehav Rev (2014) 0.92
Improving response inhibition in Parkinson's disease with atomoxetine. Biol Psychiatry (2014) 0.91
Animal models to guide clinical drug development in ADHD: lost in translation? Br J Pharmacol (2011) 0.91
Levodopa medication does not influence motor inhibition or conflict resolution in a conditional stop-signal task in Parkinson's disease. Exp Brain Res (2011) 0.90
Cognitive control in alcohol use disorder: deficits and clinical relevance. Rev Neurosci (2014) 0.89
D₁ receptor activation improves vigilance in rats as measured by the 5-choice continuous performance test. Psychopharmacology (Berl) (2011) 0.89
Behavioral inhibition in mice bred for high vs. low levels of methamphetamine consumption or sensitization. Psychopharmacology (Berl) (2012) 0.89
Selective serotonin reuptake inhibition modulates response inhibition in Parkinson's disease. Brain (2014) 0.89
Atomoxetine modulates spontaneous and sensory-evoked discharge of locus coeruleus noradrenergic neurons. Neuropharmacology (2012) 0.89
Serotonin 2A receptors, citalopram and tryptophan-depletion: a multimodal imaging study of their interactions during response inhibition. Neuropsychopharmacology (2012) 0.88
Higher levels of trait impulsiveness and a less effective response inhibition are linked to more intense cue-elicited craving for alcohol in alcohol-dependent patients. Psychopharmacology (Berl) (2013) 0.88
Impulsivity and apathy in Parkinson's disease. J Neuropsychol (2013) 0.87
Multiple modes of impulsivity in Parkinson's disease. PLoS One (2014) 0.87
Further evidence of the heterogeneous nature of impulsivity. Pers Individ Dif (2015) 0.86
'Roid rage in rats? Testosterone effects on aggressive motivation, impulsivity and tyrosine hydroxylase. Physiol Behav (2012) 0.86
Inhibitory control in mind and brain 2.0: blocked-input models of saccadic countermanding. Psychol Rev (2015) 0.86
Response inhibition and interference control in obsessive-compulsive spectrum disorders. Front Hum Neurosci (2014) 0.85
Imbalanced Activity in the Orbitofrontal Cortex and Nucleus Accumbens Impairs Behavioral Inhibition. Curr Biol (2016) 0.84
The relationship between impulsivity and craving in alcohol dependent patients. Psychopharmacology (Berl) (2012) 0.84
Reinforcement, dopamine and rodent models in drug development for ADHD. Neurotherapeutics (2012) 0.84
Guanfacine enhances inhibitory control and attentional shifting in early abstinent cocaine-dependent individuals. J Psychopharmacol (2015) 0.84
Variable delay-to-signal: a fast paradigm for assessment of aspects of impulsivity in rats. Front Behav Neurosci (2013) 0.84
Striatal D1- and D2-type dopamine receptors are linked to motor response inhibition in human subjects. J Neurosci (2015) 0.84
Vigor of movements and the cost of time in decision making. J Neurosci (2014) 0.83
Multidimensional measures of impulsivity in obsessive-compulsive disorder: cannot wait and stop. PLoS One (2014) 0.83
Neural correlates of a Go/NoGo task with alcohol stimuli in light and heavy young drinkers. Behav Brain Res (2014) 0.82
Acute ethanol administration and reinforcer magnitude reduction both reduce responding and increase response latency in a go/no-go task. Alcohol Clin Exp Res (2012) 0.82
Tryptophan Depletion Promotes Habitual over Goal-Directed Control of Appetitive Responding in Humans. Int J Neuropsychopharmacol (2015) 0.82
The influence of emotions on cognitive control: feelings and beliefs-where do they meet? Front Hum Neurosci (2013) 0.82
Stress and alcohol cues exert conjoint effects on go and stop signal responding in male problem drinkers. Neuropsychopharmacology (2010) 0.82
Inhibitory control effects in adolescent binge eating and consumption of sugar-sweetened beverages and snacks. Appetite (2014) 0.81
Deficits in a Simple Visual Go/No-go Discrimination Task in Two Mouse Models of Huntington's Disease. PLoS Curr (2013) 0.81
Does impulsivity change rate dependently following stimulant administration? A translational selective review and re-analysis. Psychopharmacology (Berl) (2015) 0.81
Should I stop or should I go? The role of associations and expectancies. J Exp Psychol Hum Percept Perform (2015) 0.81
Proactive and reactive inhibitory control in rats. Front Neurosci (2014) 0.81
Fronto-striatal circuits in response-inhibition: Relevance to addiction. Brain Res (2014) 0.80
Response inhibition and serotonin in autism: a functional MRI study using acute tryptophan depletion. Brain (2014) 0.80
Response inhibition and response monitoring in a saccadic double-step task in schizophrenia. Brain Cogn (2015) 0.80
Prefrontal hypoactivity associated with impaired inhibition in stimulant-dependent individuals but evidence for hyperactivation in their unaffected siblings. Neuropsychopharmacology (2013) 0.80
On the improvement of inhibitory response control and visuospatial attention by indirect and direct adrenoceptor agonists. Psychopharmacology (Berl) (2011) 0.80
Frontostriatal circuits and the development of bulimia nervosa. Front Behav Neurosci (2014) 0.79
Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures. Hum Brain Mapp (2016) 0.79
Response disinhibition evoked by the administration of nicotine and nicotine-associated contextual cues. Drug Alcohol Depend (2009) 0.79
Role of serotonin transporter function in rat orbitofrontal cortex in impulsive choice. Behav Brain Res (2015) 0.78
Cognitive control of gaze in bipolar disorder and schizophrenia. Psychiatry Res (2014) 0.78
No Effects of Bilateral tDCS over Inferior Frontal Gyrus on Response Inhibition and Aggression. PLoS One (2015) 0.78
What Is Trained During Food Go/No-Go Training? A Review Focusing on Mechanisms and a Research Agenda. Curr Addict Rep (2017) 0.77
A simultaneous modulation of reactive and proactive inhibition processes by anodal tDCS on the right inferior frontal cortex. PLoS One (2014) 0.77
Stop-related subthalamic beta activity indexes global motor suppression in Parkinson's disease. Mov Disord (2016) 0.77
Negative occasion setting in juvenile rats. Behav Processes (2016) 0.77
Atomoxetine restores the response inhibition network in Parkinson's disease. Brain (2016) 0.77
Enhanced inhibitory control by neuropeptide Y Y5 receptor blockade in rats. Psychopharmacology (Berl) (2014) 0.77
THE ROLE OF RESPONSE INHIBITION IN MEDICATED AND UNMEDICATED OBSESSIVE-COMPULSIVE DISORDER PATIENTS: EVIDENCE FROM THE STOP-SIGNAL TASK. Depress Anxiety (2016) 0.77
Cognitive Function as a Transdiagnostic Treatment Target in Stimulant Use Disorders. J Dual Diagn (2016) 0.77
Serotonergic modulation of 'waiting impulsivity' is mediated by the impulsivity phenotype in humans. Transl Psychiatry (2016) 0.77
Connectomic and Surface-Based Morphometric Correlates of Acute Mild Traumatic Brain Injury. Front Hum Neurosci (2016) 0.76
Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull (1997) 13.33
Inhibition and the right inferior frontal cortex. Trends Cogn Sci (2004) 9.78
Cortical and subcortical contributions to Stop signal response inhibition: role of the subthalamic nucleus. J Neurosci (2006) 6.51
A psychomotor stimulant theory of addiction. Psychol Rev (1987) 6.42
Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans. Nat Neurosci (2003) 5.94
Immature frontal lobe contributions to cognitive control in children: evidence from fMRI. Neuron (2002) 5.77
The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology (Berl) (2002) 4.78
Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science (1999) 4.70
Right hemispheric dominance of inhibitory control: an event-related functional MRI study. Proc Natl Acad Sci U S A (1999) 4.62
Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci Biobehav Rev (2004) 4.38
Error-related brain activation during a Go/NoGo response inhibition task. Hum Brain Mapp (2001) 4.08
Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology (2002) 3.79
Attention deficit disorder: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry (1996) 3.56
Mapping motor inhibition: conjunctive brain activations across different versions of go/no-go and stop tasks. Neuroimage (2001) 3.51
Characterizing cognition in ADHD: beyond executive dysfunction. Trends Cogn Sci (2006) 3.47
The neural basis of inhibition in cognitive control. Neuroscientist (2007) 3.37
Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6). Neuroscience (1983) 3.26
Impaired inhibitory control of behavior in chronic cocaine users. Drug Alcohol Depend (2002) 3.15
Right inferior prefrontal cortex mediates response inhibition while mesial prefrontal cortex is responsible for error detection. Neuroimage (2003) 3.07
Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biol Psychiatry (2005) 3.04
Perseverative interference in monkeys following selective lesions of the inferior prefrontal convexity. Exp Brain Res (1970) 3.03
The pharmacology of impulsive behaviour in rats: the effects of drugs on response choice with varying delays of reinforcement. Psychopharmacology (Berl) (1996) 2.97
Behavioral models of impulsivity in relation to ADHD: translation between clinical and preclinical studies. Clin Psychol Rev (2006) 2.96
Progressive increase of frontostriatal brain activation from childhood to adulthood during event-related tasks of cognitive control. Hum Brain Mapp (2006) 2.95
Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study. Proc Natl Acad Sci U S A (1998) 2.91
Modafinil: a review of neurochemical actions and effects on cognition. Neuropsychopharmacology (2007) 2.88
The cognitive neuroscience of response inhibition: relevance for genetic research in attention-deficit/hyperactivity disorder. Biol Psychiatry (2004) 2.88
Common inhibitory mechanism in human inferior prefrontal cortex revealed by event-related functional MRI. Brain (1999) 2.84
Homology in behavioural pharmacology: an approach to animal models of human cognition. Behav Pharmacol (1998) 2.74
Deficits in response inhibition associated with chronic methamphetamine abuse. Drug Alcohol Depend (2005) 2.67
Shifting and stopping: fronto-striatal substrates, neurochemical modulation and clinical implications. Philos Trans R Soc Lond B Biol Sci (2007) 2.66
Do rats have prefrontal cortex? The rose-woolsey-akert program reconsidered. J Cogn Neurosci (1995) 2.65
A mechanistic account of striatal dopamine function in human cognition: psychopharmacological studies with cabergoline and haloperidol. Behav Neurosci (2006) 2.56
Acute administration of d-amphetamine decreases impulsivity in healthy volunteers. Neuropsychopharmacology (2002) 2.55
Abnormal brain activation during inhibition and error detection in medication-naive adolescents with ADHD. Am J Psychiatry (2005) 2.52
Stimulation of the subthalamic region facilitates the selection and inhibition of motor responses in Parkinson's disease. J Cogn Neurosci (2006) 2.48
Orbitofrontal lesions in rats impair reversal but not acquisition of go, no-go odor discriminations. Neuroreport (2002) 2.44
Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci (2001) 2.41
Neurochemical modulation of response inhibition and probabilistic learning in humans. Science (2006) 2.41
Limbic corticostriatal systems and delayed reinforcement. Ann N Y Acad Sci (2004) 2.24
Neural systems implicated in delayed and probabilistic reinforcement. Neural Netw (2006) 2.24
Prefrontal serotonin depletion affects reversal learning but not attentional set shifting. J Neurosci (2005) 2.24
Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav Brain Res (1998) 2.21
Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry (2001) 2.21
Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology (Berl) (2002) 2.17
Effects of dopaminergic drugs on delayed reward as a measure of impulsive behavior in rats. Psychopharmacology (Berl) (2000) 2.16
No-go dominant brain activity in human inferior prefrontal cortex revealed by functional magnetic resonance imaging. Eur J Neurosci (1998) 2.10
Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. J Neurochem (1997) 2.08
Fractionating impulsivity: contrasting effects of central 5-HT depletion on different measures of impulsive behavior. Neuropsychopharmacology (2004) 2.03
Stimulants: Therapeutic actions in ADHD. Neuropsychopharmacology (2006) 2.02
Response inhibition in AD/HD, CD, comorbid AD/HD + CD, anxious, and control children: a meta-analysis of studies with the stop task. J Child Psychol Psychiatry (1998) 2.02
Stop-signal reaction-time task performance: role of prefrontal cortex and subthalamic nucleus. Cereb Cortex (2007) 1.95
Motor inhibition and cognitive flexibility in obsessive-compulsive disorder and trichotillomania. Am J Psychiatry (2006) 1.92
The neuropsychiatry of impulsivity. Curr Opin Psychiatry (2007) 1.90
Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry (2003) 1.89
Effects of d-amphetamine and ethanol on a measure of behavioral inhibition in humans. Behav Neurosci (2000) 1.87
Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder. Behav Brain Funct (2005) 1.87
Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanisms. Psychopharmacology (Berl) (1997) 1.83
Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat. Neuropsychopharmacology (2007) 1.81
Effects of methylphenidate on inhibitory control in hyperactive children. J Abnorm Child Psychol (1989) 1.64
Altered neural substrates of cognitive control in childhood ADHD: evidence from functional magnetic resonance imaging. Am J Psychiatry (2005) 1.63
The orbital cortex in rats topographically projects to central parts of the caudate-putamen complex. Neurosci Lett (2007) 1.63
Inhibitory control in rats performing a stop-signal reaction-time task: effects of lesions of the medial striatum and d-amphetamine. Behav Neurosci (2003) 1.59
5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion. Psychopharmacology (Berl) (2004) 1.58
The effects of tryptophan depletion on cognitive and affective processing in healthy volunteers. Psychopharmacology (Berl) (2002) 1.56
Inhibition of ongoing responses in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry (2004) 1.54
Deficits in impulse control associated with tonically-elevated serotonergic function in rat prefrontal cortex. Neuropsychopharmacology (2002) 1.52
Testing computational models of dopamine and noradrenaline dysfunction in attention deficit/hyperactivity disorder. Neuropsychopharmacology (2006) 1.50
Evaluating the endophenotype model of ADHD neuropsychological deficit: results for parents and siblings of children with ADHD combined and inattentive subtypes. J Abnorm Psychol (2004) 1.46
Deficient inhibitory control in attention deficit hyperactivity disorder. J Abnorm Child Psychol (1995) 1.44
Stop signal response inhibition is not modulated by tryptophan depletion or the serotonin transporter polymorphism in healthy volunteers: implications for the 5-HT theory of impulsivity. Psychopharmacology (Berl) (2005) 1.43
Dopamine transporter genotype conveys familial risk of attention-deficit/hyperactivity disorder through striatal activation. J Am Acad Child Adolesc Psychiatry (2008) 1.42
Differential effects of modafinil and methylphenidate on stop-signal reaction time task performance in the rat, and interactions with the dopamine receptor antagonist cis-flupenthixol. Psychopharmacology (Berl) (2007) 1.42
Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder. Biol Psychiatry (2004) 1.38
The effect of citalopram pretreatment on neuronal responses to neuropsychological tasks in normal volunteers: an FMRI study. Neuropsychopharmacology (2005) 1.38
Animal models of attention-deficit hyperactivity disorder. Brain Res Brain Res Rev (2003) 1.36
Effects of central 5-hydroxytryptamine depletion on sensitivity to delayed and probabilistic reinforcement. Psychopharmacology (Berl) (2000) 1.36
Restraint and cancellation: multiple inhibition deficits in attention deficit hyperactivity disorder. J Abnorm Child Psychol (2007) 1.34
Central serotonin depletion impairs both the acquisition and performance of a symmetrically reinforced go/no-go conditional visual discrimination. Behav Brain Res (1999) 1.34
Go - no go learning after frontal lobe lesions in humans. Cortex (1975) 1.30
Effect of tryptophan depletion on impulsive behavior in men with or without a family history of alcoholism. Behav Brain Res (2002) 1.28
Inhibition of ongoing responses following frontal, nonfrontal, and basal ganglia lesions. Neuropsychology (2003) 1.27
Striatal dysfunction in attention deficit and hyperkinetic disorder. Arch Neurol (1989) 1.27
Association of the dopamine D4 receptor gene 7-repeat allele with neuropsychological test performance of children with ADHD. Am J Psychiatry (2004) 1.26
Reexamination of functional subdivisions of the rodent prefrontal cortex. Exp Neurol (1983) 1.26
Inhibitory motor control in stop paradigms: review and reinterpretation of neural mechanisms. Acta Psychol (Amst) (1999) 1.25
Behavioral disinhibition induced by tryptophan depletion in nonalcoholic young men with multigenerational family histories of paternal alcoholism. Am J Psychiatry (1999) 1.24
Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors. Am J Psychiatry (1997) 1.21
Performance of children with attention deficit hyperactivity disorder (ADHD) on a test battery of impulsiveness. Child Neuropsychol (2007) 1.20
The effect of tryptophan depletion and enhancement on subjective and behavioural aggression in normal male subjects. Psychopharmacology (Berl) (1995) 1.16
Tryptophan depletion reduces right inferior prefrontal activation during response inhibition in fast, event-related fMRI. Psychopharmacology (Berl) (2005) 1.13
Acute effects of oral cocaine on inhibitory control of behavior in humans. Drug Alcohol Depend (2002) 1.12
Lesions of the medial prefrontal cortex or nucleus accumbens core do not impair inhibitory control in rats performing a stop-signal reaction time task. Behav Brain Res (2003) 1.11
Effects of d-amphetamine and alcohol on a measure of behavioral inhibition in rats. Behav Neurosci (2000) 1.11
Selective inhibition in children with attention-deficit hyperactivity disorder off and on stimulant medication. J Abnorm Child Psychol (2003) 1.11
Lowering of serotonin by rapid tryptophan depletion increases impulsiveness in normal individuals. Psychopharmacology (Berl) (2002) 1.11
Impaired response inhibition in obsessive compulsive disorder. Eur Psychiatry (2007) 1.10
Methylphenidate-evoked changes in striatal dopamine correlate with inattention and impulsivity in adolescents with attention deficit hyperactivity disorder. Neuroimage (2005) 1.10
Selective deficit in no-go performance induced by blockade of prefrontal cortical alpha 2-adrenoceptors in monkeys. Neuroreport (2003) 1.09
Inhibitory dysfunction in hyperactive boys. Behav Brain Res (1998) 1.08
Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci (2005) 16.18
Inhibition and the right inferior frontal cortex. Trends Cogn Sci (2004) 9.78
Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science (2007) 6.75
Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans. Nat Neurosci (2003) 5.94
Putting a spin on the dorsal-ventral divide of the striatum. Trends Neurosci (2004) 5.55
Review. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction. Philos Trans R Soc Lond B Biol Sci (2008) 4.85
High impulsivity predicts the switch to compulsive cocaine-taking. Science (2008) 4.76
Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci Biobehav Rev (2004) 4.38
Cognition in schizophrenia: summary Nice Consultation Meeting 2012. Eur Neuropsychopharmacol (2013) 3.99
Impulsivity, compulsivity, and top-down cognitive control. Neuron (2011) 3.96
Defining the neural mechanisms of probabilistic reversal learning using event-related functional magnetic resonance imaging. J Neurosci (2002) 3.50
Contrasting roles of basolateral amygdala and orbitofrontal cortex in impulsive choice. J Neurosci (2004) 3.48
The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. Brain (2009) 3.03
Behavioral models of impulsivity in relation to ADHD: translation between clinical and preclinical studies. Clin Psychol Rev (2006) 2.96
Serotoninergic regulation of emotional and behavioural control processes. Trends Cogn Sci (2007) 2.95
Abnormal brain structure implicated in stimulant drug addiction. Science (2012) 2.85
Inhibition and impulsivity: behavioral and neural basis of response control. Prog Neurobiol (2013) 2.85
The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. Brain (2003) 2.81
Appetitive behavior: impact of amygdala-dependent mechanisms of emotional learning. Ann N Y Acad Sci (2003) 2.70
Parallel and interactive learning processes within the basal ganglia: relevance for the understanding of addiction. Behav Brain Res (2008) 2.61
Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review. Neuropsychopharmacology (2009) 2.60
L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease. Neuropsychologia (2003) 2.55
Differential control over cocaine-seeking behavior by nucleus accumbens core and shell. Nat Neurosci (2004) 2.52
Serotonin modulates behavioral reactions to unfairness. Science (2008) 2.49
Dopamine release in the dorsal striatum during cocaine-seeking behavior under the control of a drug-associated cue. J Neurosci (2002) 2.49
Serotonin selectively influences moral judgment and behavior through effects on harm aversion. Proc Natl Acad Sci U S A (2010) 2.47
Neurochemical modulation of response inhibition and probabilistic learning in humans. Science (2006) 2.41
Limbic corticostriatal systems and delayed reinforcement. Ann N Y Acad Sci (2004) 2.24
Disruption in the balance between goal-directed behavior and habit learning in obsessive-compulsive disorder. Am J Psychiatry (2011) 2.24
Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry. J Neurosci (2003) 2.22
Serotonergic and dopaminergic modulation of gambling behavior as assessed using a novel rat gambling task. Neuropsychopharmacology (2009) 2.21
Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives. Science (2008) 2.20
The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort. J Neurol Neurosurg Psychiatry (2013) 2.20
Neurobehavioral mechanisms of impulsivity: fronto-striatal systems and functional neurochemistry. Pharmacol Biochem Behav (2007) 2.19
The application of the 5-choice serial reaction time task for the assessment of visual attentional processes and impulse control in rats. Nat Protoc (2008) 2.17
Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology (Berl) (2002) 2.17
Drug addiction endophenotypes: impulsive versus sensation-seeking personality traits. Biol Psychiatry (2010) 2.13
A componential analysis of task-switching deficits associated with lesions of left and right frontal cortex. Brain (2004) 2.11
Reflection impulsivity in current and former substance users. Biol Psychiatry (2006) 2.09
The natural history of treated Parkinson's disease in an incident, community based cohort. J Neurol Neurosurg Psychiatry (2011) 2.08
Cognitive dysfunction and anxious-impulsive personality traits are endophenotypes for drug dependence. Am J Psychiatry (2012) 2.05
Decision-making in the adolescent brain. Nat Neurosci (2012) 2.05
Reconciling the role of serotonin in behavioral inhibition and aversion: acute tryptophan depletion abolishes punishment-induced inhibition in humans. J Neurosci (2009) 2.04
Fractionating impulsivity: contrasting effects of central 5-HT depletion on different measures of impulsive behavior. Neuropsychopharmacology (2004) 2.03
Abnormal structure of frontostriatal brain systems is associated with aspects of impulsivity and compulsivity in cocaine dependence. Brain (2011) 2.00
Adolescent impulsivity phenotypes characterized by distinct brain networks. Nat Neurosci (2012) 1.98
Stop-signal reaction-time task performance: role of prefrontal cortex and subthalamic nucleus. Cereb Cortex (2007) 1.95
Time-limited modulation of appetitive Pavlovian memory by D1 and NMDA receptors in the nucleus accumbens. Proc Natl Acad Sci U S A (2005) 1.94
Motor inhibition and cognitive flexibility in obsessive-compulsive disorder and trichotillomania. Am J Psychiatry (2006) 1.92
Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry (2003) 1.89
Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study. Biol Psychiatry (2008) 1.89
Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders. Neuropsychopharmacology (2005) 1.89
From the ventral to the dorsal striatum: devolving views of their roles in drug addiction. Neurosci Biobehav Rev (2013) 1.88
Lesions of the medial striatum in monkeys produce perseverative impairments during reversal learning similar to those produced by lesions of the orbitofrontal cortex. J Neurosci (2008) 1.88
Learning and cognitive flexibility: frontostriatal function and monoaminergic modulation. Curr Opin Neurobiol (2010) 1.85
Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder. Biol Psychiatry (2007) 1.82
Neurocognitive endophenotypes of obsessive-compulsive disorder. Brain (2007) 1.81
Profile of executive and memory function associated with amphetamine and opiate dependence. Neuropsychopharmacology (2006) 1.81
Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat. Neuropsychopharmacology (2007) 1.81
The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder. Biol Psychiatry (2011) 1.80
Double dissociation between serotonergic and dopaminergic modulation of medial prefrontal and orbitofrontal cortex during a test of impulsive choice. Cereb Cortex (2005) 1.80
Chronic cocaine but not chronic amphetamine use is associated with perseverative responding in humans. Psychopharmacology (Berl) (2008) 1.79
Frontal responses during learning predict vulnerability to the psychotogenic effects of ketamine: linking cognition, brain activity, and psychosis. Arch Gen Psychiatry (2006) 1.78
Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET. Brain (2002) 1.75
Global 5-HT depletion attenuates the ability of amphetamine to decrease impulsive choice on a delay-discounting task in rats. Psychopharmacology (Berl) (2003) 1.73
Differential responses in human striatum and prefrontal cortex to changes in object and rule relevance. J Neurosci (2004) 1.71
Fear-conditioning mechanisms associated with trait vulnerability to anxiety in humans. Neuron (2011) 1.71
Personality, addiction, dopamine: insights from Parkinson's disease. Neuron (2009) 1.71
Impaired cognitive flexibility and motor inhibition in unaffected first-degree relatives of patients with obsessive-compulsive disorder. Am J Psychiatry (2007) 1.71
Lower ventral striatal activation during reward anticipation in adolescent smokers. Am J Psychiatry (2011) 1.70
ROAMER: roadmap for mental health research in Europe. Int J Methods Psychiatr Res (2014) 1.67
L-DOPA disrupts activity in the nucleus accumbens during reversal learning in Parkinson's disease. Neuropsychopharmacology (2006) 1.66
Effects of selective excitotoxic lesions of the nucleus accumbens core, anterior cingulate cortex, and central nucleus of the amygdala on autoshaping performance in rats. Behav Neurosci (2002) 1.65
Striatal contributions to working memory: a functional magnetic resonance imaging study in humans. Eur J Neurosci (2004) 1.64
Prediction error during retrospective revaluation of causal associations in humans: fMRI evidence in favor of an associative model of learning. Neuron (2004) 1.64
High impulsivity predicts relapse to cocaine-seeking after punishment-induced abstinence. Biol Psychiatry (2009) 1.63
Dopamine release in dissociable striatal subregions predicts the different effects of oral methylphenidate on reversal learning and spatial working memory. J Neurosci (2009) 1.61
White matter abnormalities in patients with obsessive-compulsive disorder and their first-degree relatives. Am J Psychiatry (2008) 1.60
5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion. Psychopharmacology (Berl) (2004) 1.58
Functional neuroimaging of avoidance habits in obsessive-compulsive disorder. Am J Psychiatry (2014) 1.56
Risk taking and the adolescent reward system: a potential common link to substance abuse. Am J Psychiatry (2011) 1.56
Effects of orbitofrontal, infralimbic and prelimbic cortical lesions on serial spatial reversal learning in the rat. Behav Brain Res (2007) 1.55
Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease. Neuropsychologia (2004) 1.54
Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study. Neurology (2013) 1.53
Deficits in impulse control associated with tonically-elevated serotonergic function in rat prefrontal cortex. Neuropsychopharmacology (2002) 1.52
Catechol O-methyltransferase Val158Met genotype influences frontoparietal activity during planning in patients with Parkinson's disease. J Neurosci (2007) 1.50
The frontal cortex of the rat and visual attentional performance: dissociable functions of distinct medial prefrontal subregions. Cereb Cortex (2002) 1.49
Serotonergic modulation of prefrontal cortex during negative feedback in probabilistic reversal learning. Neuropsychopharmacology (2005) 1.49
The contributions of lesion laterality and lesion volume to decision-making impairment following frontal lobe damage. Neuropsychologia (2003) 1.48
Translational approaches to frontostriatal dysfunction in attention-deficit/hyperactivity disorder using a computerized neuropsychological battery. Biol Psychiatry (2010) 1.45
Differential roles of dopamine D1 and D2 receptors in the nucleus accumbens in attentional performance on the five-choice serial reaction time task. Neuropsychopharmacology (2006) 1.45
Detecting dementia: novel neuropsychological markers of preclinical Alzheimer's disease. Dement Geriatr Cogn Disord (2003) 1.43
Differential effects of modafinil and methylphenidate on stop-signal reaction time task performance in the rat, and interactions with the dopamine receptor antagonist cis-flupenthixol. Psychopharmacology (Berl) (2007) 1.42
Discrimination learning, reversal, and set-shifting in first-episode schizophrenia: stability over six years and specific associations with medication type and disorganization syndrome. Biol Psychiatry (2009) 1.41
Prefrontal cortical-ventral striatal interactions involved in affective modulation of attentional performance: implications for corticostriatal circuit function. J Neurosci (2004) 1.41
Dissociable effects of lesions to orbitofrontal cortex subregions on impulsive choice in the rat. J Neurosci (2011) 1.40
Functional interaction between the hippocampus and nucleus accumbens shell is necessary for the acquisition of appetitive spatial context conditioning. J Neurosci (2008) 1.40